Client News

[PR Newswire] - VANCOUVER, British Columbia and MENLO PARK, Calif., March 28, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will present three abstracts at the American Association of Cancer Research (AACR) Annual Meeting. The abstracts are based on research conducted with DelMar's lead anti-cancer product candidate, VAL-083 (dianhydrogalactitol), a "first-in-class" small-molecule DNA-targeting agent. The AACR Annual Meeting will be held April 1-5, 2017 in Washington, D.C.
Posted: March 28, 2017, 12:30 pm
[GlobeNewswire] - WIXOM, Mich., March 28, 2017-- Rockwell Medical, Inc., a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products for the treatment ...
Posted: March 28, 2017, 12:30 pm
[Accesswire] - Upcoming AWS Coverage on Patheon Post-Earnings Results LONDON, UK / ACCESSWIRE / March 28, 2017 / Active Wall St. blog coverage looks at the headline from Allergan PLC (NYSE: AGN ) and Paratek Pharmaceuticals, ...
Posted: March 28, 2017, 12:15 pm
[GlobeNewswire] - --Investigational New Drug approval from Korean Ministry of Food and Drug Safety represents a key milestone in Catalyst’ s Factor IX development program--. --Catalyst’ s collaborator, ISU Abxis, plans ...
Posted: March 28, 2017, 12:01 pm
[GlobeNewswire] - BOSTON, March 28, 2017-- Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will present at the following ...
Posted: March 28, 2017, 12:00 pm
Posted: March 28, 2017, 11:14 am
Posted: March 28, 2017, 11:14 am
[Business Wire] - Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2016.
Posted: March 28, 2017, 11:00 am
Posted: March 28, 2017, 11:00 am
[GlobeNewswire] - TEL AVIV, Israel, March 28, 2017-- VBL Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced ...
Posted: March 28, 2017, 11:00 am
[Business Wire] - BioTime, Inc. , a clinical stage biotechnology company developing and commercializing products addressing degenerative disease, today announced the successful defense of two key patents from challenge before the European Patent Office Opposition division.
Posted: March 28, 2017, 11:00 am
[GlobeNewswire] - DAVIS, Calif. and REHOVOT, Israel, March 28, 2017-- Marrone Bio Innovations Inc.,, a leading global provider of bio-based pest management and plant health products, and Evogene Ltd., a leading company ...
Posted: March 28, 2017, 11:00 am
[PR Newswire] - SAN DIEGO, March 28, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present preclinical ...
Posted: March 28, 2017, 10:01 am